Table 4.
Correlation of clinical and laboratory variables with CT severity index in laboratory-confirmed and clinically diagnosed COVID-19 subgroups
| Variables | CT-SI of laboratory-confirmed COVID-19 patients (n=65) | CT-SI of clinically diagnosed COVID-19 patients (n=40) |
|---|---|---|
| Age (years) | ||
| r | 0.251 | 0.662 |
| p | 0.144 | 0.001 |
|
| ||
| Max diameter of lesion (cm) | ||
| r | 0.627 | 0.380 |
| p | 0.001 | 0.019 |
|
| ||
| WBC count | ||
| r | −0.035 | 0.058 |
| p | 0.781 | 0.720 |
|
| ||
| Neutrophil count | ||
| r | 0.098 | −0.311 |
| p | 0.480 | 0.084 |
|
| ||
| Lymphocyte count | ||
| r | −0.187 | −0.012 |
| p | 0.139 | 0.940 |
|
| ||
| Neutrophil to lymphocyte ratio | ||
| r | 0.336 | −0.197 |
| p | 0.013 | 0.280 |
|
| ||
| CRP | ||
| r | 0.438 | 0.270 |
| p | 0.001 | 0.101 |
|
| ||
| LDH | ||
| r | 0.318 | −0.049 |
| p | 0.023 | 0.782 |
CT, computed tomography; COVID-19, coronavirus disease 2019; CT-SI, computed tomography severity index; WBC, white blood cell; CRP, C-reactive protein; LDH, lactate dehydrogenase.